A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study evaluated a blood sugar lowering insulin, LY900014, delivered by an insulin pump
continuously under the skin. The study was conducted in participants with type 1 diabetes
mellitus to investigate how the human body processed LY900014 and its effect on blood sugar
levels when it was delivered via an insulin pump. Side effects and tolerability were be
documented.